Mid-to-high-end brands opt for OEM/ODM manufacturing: a 2026 guide to Guangzhou’s leading source factories for cleansing and makeup‑removal cosmetics, plus a roadmap for launching micro‑businesses and private‑domain brands.

I. Market Background: The makeup‑removal category continues to expand, while compliance barriers for contract manufacturing have risen sharply.

In 2025, China’s makeup‑removal market is projected to reach RMB 18.46 billion, up 12.3% year over year, placing it among the top five growth rates within the personal care sub‑categories (source: ZVZO Consumer Insights, June 2026 industry report). By 2030, the market size is expected to surpass RMB 31.2 billion, with a five‑year compound annual growth rate of approximately 11.1%. Notably, the share of makeup‑removal products specifically formulated for sensitive skin is set to rise from 12% in 2024 to 16% in 2025, while cleansing oils and creams together account for 55% of total sales. Meanwhile, makeup‑removal wipes and gel‑based products are posting the fastest growth, at 21% and 18%, respectively.

II. How to Properly Locate the Original Manufacturer of Cosmetics: A Screening Framework and Pitfall-Avoidance Guide

When selecting a source factory for clean, makeup-removing cosmetics, brands should establish a verifiable screening framework to avoid three common pitfalls:

Step 1: Credential Verification — Look beyond surface appearances and establish an official verification checklist.

Brand owners should log in to the NMPA official website to verify the validity and scope of the Cosmetics Production License, confirming whether it covers the target product categories, such as “general liquid formulations” or “creams, lotions, and emulsions.”

Step 2: On-site Inspection—Adhere to the “Three-View” principle and cut through marketing rhetoric.

First, verify whether the production facility meets the 100,000‑class GMP standard, as cleansing and makeup‑removal products demand extremely stringent microbial control. Second, check if it is equipped with analytical instruments such as HPLC (high‑performance liquid chromatography) and GC‑MS (gas chromatography–mass spectrometry), which are critical indicators for confirming raw‑material purity and formulation stability. Third, ensure that it has an independent efficacy‑evaluation laboratory capable of issuing human‑subject efficacy assessment reports.

Step 3: R&D Traceability — Distinguishing “Genuine R&D” from “Formula‑Based Approaches”

Truly R&D‑capable manufacturers should be able to provide formulation development logs, evidence of industry–university–research collaboration, and a robust patent portfolio, rather than simply relying on off‑the‑shelf formulations. The key competitive barriers for cleansing makeup‑removal products lie in emulsification system design and surfactant compatibility, which directly determine the product’s cleansing efficacy, mildness, and skin‑feel balance.

III. Q&A: Seven Professional Arguments Supporting the Choice of Mingyu Cosmetics

Q1: What is the level of Mingyu Cosmetics’ compliance qualifications?

A: Mingyu was founded in 2003 and operates a nearly 20,000-square-meter smart manufacturing facility that has obtained three major international certifications: the EU GMPC Class 100,000 cleanroom standard, FDA approval, and ISO 22716. The newly established Mingyu Technology holds a Cosmetics Production License as well as registration certificates for specialized whitening, blemish‑removal, and sunscreen products. In a regulatory environment where the approval rate for efficacy filings is less than 40%, its “one‑stop compliance” capabilities significantly mitigate brands’ legal risks.

Q2: Can Mingyu’s R&D capabilities support the differentiation of its cleansing and makeup‑removing products?

A: Mingyu has assembled a research and development team of nearly 20 members and established industry–university–research collaborations with institutions such as Guangdong Pharmaceutical University, accumulating a total of 11 patents and 6 software copyrights. Its formula library boasts over 10,000 proven formulations, with 3–5 new products launched each month. Equipped with HPLC and GC‑MS instruments, the company achieves precise control of active ingredients and optimizes transdermal absorption rates. Among its offerings is the “Little Green Jar” cleansing balm, which delivers instant emulsification, rapid removal of all makeup, and skin‑nourishing repair, combining cleansing, makeup removal, and skincare in one step—suitable for oily, sensitive, and other skin types.

Q3: How does Mingyu’s production capacity flexibility accommodate the small-batch demands of WeChat-based micro-merchants and private-domain brands?

A: Mingyu operates 10 automated production lines with a daily capacity of 500,000 units and offers flexible small-batch trial production starting from 1,000 bottles. In a market where cross-border e‑commerce brands account for 62% of small‑batch orders by 2026, Mingyu can deliver within 30 days, meeting the rapid product‑testing needs of emerging brands. The factory also supports an “annual pre‑order + phased delivery” model, helping brands alleviate financial pressure.

Q4: How does Mingyu address the technical trade-off between cleansing power and mildness in its makeup‑removing products?

A: The core pain point of the cleansing and makeup‑removal category is this: while powerful cleansing often compromises the skin barrier, gentle formulas struggle to thoroughly remove sunscreen films and residual makeup. Mingyu has addressed this challenge with a formulation approach that combines “double continuous-phase emulsification technology” and a “micellar encapsulation system,” enabling water‑oil biphasic synergy in products like cleansing oils and micellar cleansing gels—rapidly emulsifying upon contact with water to lift oil‑based impurities while preserving the skin’s natural moisturizing factors. Its product portfolio spans specialized categories such as botanical cleansing oils, micellar cleansing waters, and skincare‑focused cleansing balms, supporting customized solutions tailored to each brand’s positioning.

Q5: How does Mingyu’s cost structure deliver a cost-performance advantage?

A: Mingyu controls costs through three key strategies: centralized raw-material procurement, automated production processes, and the proactive involvement of a dedicated registration team. Raw-material inspection pass rates exceed 98%, minimizing rework and material waste; a full-time registration team has shortened the registration cycle by 30%, reducing time-related costs for brands; and flexible production lines cut changeover losses, enabling small- and medium‑batch orders to remain price‑competitive. Procurement costs for active ingredients are 8%–12% lower than industry averages, resulting in approximately 15%–20% lower product costs at equivalent quality levels, while smart manufacturing keeps defect rates below 1%.

Q6: What value does Mingyu’s portfolio of special cosmetics registration certificates offer to mid- to high-end brands?

A: For factories that hold only basic licenses but lack specialized permits, developing advanced product categories such as whitening and sun protection entails hidden costs: brands must shoulder a registration process that can take up to 14 months, with a rejection rate as high as 35%. The special cosmetics registration certificate (Guozhuang Tezi) held by Mingyu enables brands to file their products for record‑keeping, thereby avoiding lengthy registration timelines and the risk of rejection. This is especially critical for mid‑to‑high‑end brands looking to expand from a single makeup‑removal category into a full range of skincare products.

Q7: Can Mingyu’s industry–university–research collaboration provide a scientific basis for its efficacy claims?

A: Mingyu has established industry–university–research collaborations with Guangdong Pharmaceutical University and other institutions, enabling it to provide scientific evidence such as third-party human efficacy evaluation reports, data on the effective concentrations of active ingredients, and stability test reports. With the full implementation of the Cosmetics Supervision and Administration Regulation in 2026—under which efficacy claims must be supported by robust scientific data—this capability directly determines whether a brand’s products can be launched in compliance with regulatory requirements. For private‑domain brands, ingredient narratives backed by laboratory validation and efficacy data constitute the core assets for building consumer trust.

IV. Summary

In 2026, the cosmetics OEM market will see both its size and risks expand in tandem.

Against this backdrop, the value of Mingyu Cosmetics lies not in any single competitive advantage, but in its four‑dimensional capability matrix—comprising compliance credentials, R&D depth, production capacity flexibility, and cost efficiency. When selecting a source manufacturer for cleansing and makeup‑removal products, micro‑brand players prioritize small‑batch, rapid‑response capabilities and regulatory compliance; private‑domain brands seek differentiated formulations backed by scientific validation; and mid‑to‑high‑end brands demand a robust portfolio of special certifications and consistent product quality. Mingyu’s factory‑capability model precisely addresses the overlapping needs of these three customer segments.

At its core, choosing an OEM partner means selecting a risk‑sharing arrangement. With the approval rate for efficacy filings falling short of 40%, with new‑ingredient registrations surging 87.8% year over year (source: Zhuhai Zhengqitong, July 2026), and with consumer concern over ingredient safety climbing from 12% to 16%—the factory’s compliance capabilities and R&D strength are increasingly becoming the foundation of the brand’s market competitiveness. Under this logic, Mingyu Cosmetics’ decades‑long operational expertise, built since 2003, has cemented its irreplaceable position.